148 related articles for article (PubMed ID: 17203463)
1. Roscovitine-activated HIP2 kinase induces phosphorylation of wt p53 at Ser-46 in human MCF-7 breast cancer cells.
Wesierska-Gadek J; Schmitz ML; Ranftler C
J Cell Biochem; 2007 Mar; 100(4):865-74. PubMed ID: 17203463
[TBL] [Abstract][Full Text] [Related]
2. Effect of distinct anticancer drugs on the phosphorylation of p53 protein at serine 46 in human MCF-7 breast cancer cells.
Wesierska-Gadek J; Gueorguieva M; Herbacek I; Ranftler C
Ann N Y Acad Sci; 2007 Jan; 1095():45-52. PubMed ID: 17404016
[TBL] [Abstract][Full Text] [Related]
3. Impact of roscovitine, a selective CDK inhibitor, on cancer cells: bi-functionality increases its therapeutic potential.
Wesierska-Gadek J; Borza A; Komina O; Maurer M
Acta Biochim Pol; 2009; 56(3):495-501. PubMed ID: 19724778
[TBL] [Abstract][Full Text] [Related]
4. Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells.
Węsierska-Gądek J; Gritsch D; Zulehner N; Komina O; Maurer M
J Cell Biochem; 2011 Mar; 112(3):761-72. PubMed ID: 21328450
[TBL] [Abstract][Full Text] [Related]
5. Roscovitine up-regulates p53 protein and induces apoptosis in human HeLaS(3) cervix carcinoma cells.
Wesierska-Gadek J; Wandl S; Kramer MP; Pickem C; Krystof V; Hajek SB
J Cell Biochem; 2008 Dec; 105(5):1161-71. PubMed ID: 18846503
[TBL] [Abstract][Full Text] [Related]
6. Prevention of p53 degradation in human MCF-7 cells by proteasome inhibitors does not mimic the action of roscovitine.
Ranftler C; Gueorguieva M; Wesierska-Gadek J
Ann N Y Acad Sci; 2006 Dec; 1090():234-44. PubMed ID: 17384267
[TBL] [Abstract][Full Text] [Related]
7. Rapid onset of nucleolar disintegration preceding cell cycle arrest in roscovitine-induced apoptosis of human MCF-7 breast cancer cells.
Wojciechowski J; Horky M; Gueorguieva M; Węsierska-Gądek J
Int J Cancer; 2003 Sep; 106(4):486-495. PubMed ID: 12845642
[TBL] [Abstract][Full Text] [Related]
8. Roscovitine differentially affects asynchronously growing and synchronized human MCF-7 breast cancer cells.
Maurer M; Komina O; Wesierska-Gadek J
Ann N Y Acad Sci; 2009 Aug; 1171():250-6. PubMed ID: 19723062
[TBL] [Abstract][Full Text] [Related]
9. Interference with ER-α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER-positive breast cancer cells.
Węsierska-Gądek J; Gritsch D; Zulehner N; Komina O; Maurer M
J Cell Biochem; 2011 Apr; 112(4):1103-17. PubMed ID: 21308739
[TBL] [Abstract][Full Text] [Related]
10. Phenol red reduces ROSC mediated cell cycle arrest and apoptosis in human MCF-7 cells.
Wesierska-Gadek J; Schreiner T; Gueorguieva M; Ranftler C
J Cell Biochem; 2006 Aug; 98(6):1367-79. PubMed ID: 16741967
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of human MCF-7 breast cancer cells with caspase-3 does not sensitize them to action of CDK inhibitors.
Węsierska-Gądek J; Hackl S; Zulehner N; Maurer M; Komina O
J Cell Biochem; 2011 Jan; 112(1):273-88. PubMed ID: 21080333
[TBL] [Abstract][Full Text] [Related]
12. Effect of anti-estrogen combined with roscovitine, a selective CDK inhibitor, on human breast cancer cells differing in expression of ER.
Zulehner N; Maurer M; Wesierska-Gadek J
J Exp Ther Oncol; 2011; 9(1):17-25. PubMed ID: 21275262
[TBL] [Abstract][Full Text] [Related]
13. Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin.
Wesierska-Gadek J; Gueorguieva M; Horky M
Pol J Pharmacol; 2003; 55(5):895-902. PubMed ID: 14704484
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic effects of selective CDK inhibitors on human normal and cancer cells.
Wesierska-Gadek J; Hajek SB; Sarg B; Wandl S; Walzi E; Lindner H
Biochem Pharmacol; 2008 Dec; 76(11):1503-14. PubMed ID: 18761330
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of farnesyl protein transferase sensitizes human MCF-7 breast cancer cells to roscovitine-mediated cell cycle arrest.
Wesierska-Gadek J; Maurer M; Schmid G
J Cell Biochem; 2007 Oct; 102(3):736-47. PubMed ID: 17415788
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine.
Wesierska-Gadek J; Gueorguieva M; Wojciechowski J; Horky M
Pol J Pharmacol; 2004; 56(5):635-41. PubMed ID: 15591654
[TBL] [Abstract][Full Text] [Related]
17. Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells.
Wesierska-Gadek J; Gueorguieva M; Horky M
Mol Cancer Ther; 2005 Jan; 4(1):113-24. PubMed ID: 15657359
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen enhances the anti-proliferative effect of roscovitine, a selective cyclin-dependent kinase inhibitor, on human ER-positive human breast cancer cells.
Gritsch D; Maurer M; Zulehner N; Wesierska-Gadek J
J Exp Ther Oncol; 2011; 9(1):37-45. PubMed ID: 21275264
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ornithine decarboxylase alters the roscovitine-induced mitochondrial-mediated apoptosis in MCF-7 breast cancer cells.
Arisan ED; Obakan P; Coker A; Palavan-Unsal N
Mol Med Rep; 2012 May; 5(5):1323-9. PubMed ID: 22344475
[TBL] [Abstract][Full Text] [Related]
20. Difference of cell cycle arrests induced by lidamycin in human breast cancer cells.
Liu X; He H; Feng Y; Zhang M; Ren K; Shao R
Anticancer Drugs; 2006 Feb; 17(2):173-9. PubMed ID: 16428935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
